Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Seminal plasma** is the cell-free fluid component of semen, comprising secretions from the testes, epididymides, and male accessory sex glands. It is a heterogeneous, donor-derived biological mixture containing proteins, peptides, cytokines, enzymes, hormones, ions, lipids, nucleic acids, and extracellular vesicles rather than a defined single active pharmaceutical ingredient. In the SENAVA randomized IVF study, prepared seminal plasma from the male partner was deposited intravaginally around the external cervical os after oocyte pickup as an experimental adjunct intended to influence female reproductive-tract immune and endometrial responses and potentially support implantation. The completed double-blind placebo-controlled trial reported that this intervention did not increase live-birth rates after IVF or ICSI. ([mdpi.com](https://www.mdpi.com/1422-0067/22/9/4368))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on seminal plasma.